Arne Östman Selected Research

Arne Östman Research Topics

Disease

34	Neoplasms (Cancer) 09/2021 - 09/2011
7	Breast Neoplasms (Breast Cancer) 05/2021 - 01/2016
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2013
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 02/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 06/2015
3	Neoplasm Metastasis (Metastasis) 11/2017 - 04/2016
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 11/2016
2	Insulin Resistance 03/2016 - 04/2015
1	Mesothelioma 09/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021
1	Breast Carcinoma In Situ 01/2019
1	Adenocarcinoma 01/2019
1	Disease Progression 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 03/2018
1	Ovarian Neoplasms (Ovarian Cancer) 07/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Glioma (Gliomas) 11/2016
1	Metabolic Diseases (Metabolic Disease) 03/2016
1	Obesity 03/2016
1	Body Weight (Weight, Body) 03/2016
1	Diffuse Intrinsic Pontine Glioma 07/2015
1	Carcinogenesis 06/2015
1	Hypoxia (Hypoxemia) 04/2015
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2014
1	Dermatofibrosarcoma 02/2014
1	Rhabdomyosarcoma 04/2013
1	Sarcoma (Soft Tissue Sarcoma) 04/2013

Drug/Important Bio-Agent (IBA)

10	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2021 - 04/2013
7	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2014
7	Pharmaceutical PreparationsIBA 01/2020 - 02/2014
4	Proteins (Proteins, Gene)FDA Link 06/2021 - 09/2011
4	Biological ProductsIBA 01/2019 - 04/2013
3	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 09/2021 - 01/2021
3	ChemokinesIBA 01/2020 - 10/2016
3	Glutathione (Reduced Glutathione)IBA 01/2018 - 04/2015
3	ThioredoxinsIBA 01/2018 - 04/2015
2	Keratins (Keratin)IBA 06/2021 - 11/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2015
2	Gemcitabine FDA Link 01/2019 - 06/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 01/2017
2	ParaffinIBA 10/2017 - 10/2016
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 02/2014
2	Conditioned Culture MediaIBA 01/2017 - 03/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2016 - 05/2012
2	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 04/2015
2	Insulin (Novolin)FDA Link 03/2016 - 04/2015
2	Tyrosine (L-Tyrosine)FDA Link 05/2012 - 09/2011
1	Thioredoxin Reductase 1IBA 06/2021
1	CarbonIBA 10/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	Chemokine ReceptorsIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	IntegrinsIBA 01/2019
1	Collagen Type I (Type I Collagen)IBA 01/2019
1	Claudin-2IBA 03/2018
1	Auranofin (Ridaura)FDA Link 01/2018
1	EnzymesIBA 01/2018
1	AntioxidantsIBA 01/2018
1	HMGA2 ProteinIBA 06/2017
1	Tamoxifen FDA LinkGeneric 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 11/2016
1	Caspase 3 (Caspase-3)IBA 11/2016
1	Formaldehyde (Formol)FDA Link 10/2016
1	Messenger RNA (mRNA)IBA 10/2016
1	DesminIBA 04/2016
1	MicroRNAs (MicroRNA)IBA 03/2016
1	Angiogenesis InhibitorsIBA 01/2016
1	Sunitinib (Sutent)FDA Link 01/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Semaphorin-3AIBA 01/2016
1	Neuropilin-1IBA 01/2016
1	Docetaxel (Taxotere)FDA Link 01/2016
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 10/2015
1	cabozantinibIBA 07/2015
1	dipinacoline glutamateIBA 07/2015
1	Dasatinib (BMS 354825)FDA Link 07/2015
1	Sirtuin 1IBA 06/2015
1	Thioredoxin-Disulfide ReductaseIBA 04/2015
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 04/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2015
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 04/2015
1	Protein Tyrosine PhosphatasesIBA 04/2015
1	Insulin ReceptorIBA 04/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2014
1	Monoclonal AntibodiesIBA 02/2014
1	platelet-derived growth factor C (PDGF-C)IBA 04/2013
1	LigandsIBA 04/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013

Therapy/Procedure

11	Therapeutics 01/2021 - 01/2014
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2019
2	Radiotherapy 05/2021 - 01/2021
1	Segmental Mastectomy (Lumpectomy) 05/2021
1	Castration 01/2019
1	Decompression 01/2019
1	Adjuvant Chemotherapy 01/2019
1	Fat-Restricted Diet (Diet, Fat Restricted) 03/2016
1	Aftercare (After-Treatment) 01/2016